Latest Health News

Westpac Banking Corporation reported a slight 1% decline in net profit to $3.3 billion for the first half of 2025, while business and institutional lending grew robustly. The bank maintained a solid capital position and announced a fully franked interim dividend of 76 cents per share.

Westpac Banking Corporation posted a $3.5 billion net profit for the first half of 2025, maintaining strong capital ratios and advancing its digital transformation and sustainability initiatives despite a slight earnings dip.

MedAdvisor Limited’s trading suspension has been lifted immediately following the release of an announcement about the outcome of a court application under the Corporations Act 2001.

Classic Minerals Limited has completed the sale of its Kat Gap tenements for A$7 million, using the proceeds to retire debt and accelerate exploration at its Lady Ada and Lady Magdalene gold projects within the Forrestania region.

Yowie Group Ltd has responded to ASX queries detailing a significant revenue impact from reduced store facings and clarified complex loan arrangements with Keybridge Capital Limited amid ongoing solvency concerns.

Ecofibre Limited’s shares have been suspended from trading following the appointment of voluntary administrators, reflecting severe financial distress and regulatory concerns.

Anagenics Limited has completed a significant restructuring to simplify operations and issued 35 million shares to FOS Capital as part of this process. The company confirms its going concern status and outlines plans for organic and acquisitive growth over the next year.

Forbidden Foods Limited has reported a remarkable 218% increase in April invoiced sales, driven by robust ecommerce growth and the recent integration of Oat Milk Goodness. The company is on track to surpass $4 million in annual sales, signaling strong momentum in the health and wellness FMCG sector.

Anagenics Limited has reported a net profit before tax of $138,000 for the quarter ended March 31, 2025, marking a significant turnaround following recent restructuring efforts. Despite a temporary revenue setback due to a warehousing transition, the company’s operating cash flow improved markedly.

Cazaly Resources has issued a replacement Appendix 5B for the March 2025 quarter to correct an administrative error, reaffirming a solid cash position with over six quarters of funding available.

Nuchev Limited has entered an exclusive sales agency agreement with Brauer Natural Medicines and H&S Brand Corporation, expanding its footprint in Australia's natural and complementary medicines sector. The deal covers key brands including Brauer, Skin Physics, and Rapid Loss, with potential for broader ANZ distribution.

WOTSO reports an 8% year-over-year revenue increase in Q3 FY25, driven by rising occupancy and expanding desk capacity. The company plans six new flexspace locations across Australia and New Zealand, balancing owned and leased properties.